Molecular pathogenesis of Hodgkin's lymphoma

被引:64
作者
Re, D
Küppers, R
Diehl, V
机构
[1] Burnham Inst, John Reed Lab, La Jolla, CA 92037 USA
[2] Univ Cologne, Dept Internal Med 1, Cologne, Germany
[3] Univ Duisburg Gesamthsch, Essen Med Sch, Inst Cell Biol Tumor Res, Essen, Germany
关键词
D O I
10.1200/JCO.2005.55.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
According to the WHO classification, Hodgkin's lymphoma (HL) is subdivided into a classical variant and a nodular lymphocyte predominant variant which are characterized by the presence of Hodgkin's and Reed-Sternberg (H-RS) cells or lymphocytic and histiocytic (L&H) cells, respectively. This article reviews genetic characteristics and transcriptional changes of H-RS and L&H cells, including recent knowledge about transforming mechanisms and signaling pathways that contribute to the antiapoptotic phenotype displayed by H-RS and L&H cells. We also discuss major cellular and molecular mediators contributing to the establishment and maintenance of a reactive background in HL-affected tissues, We believe that an in-depth understanding of the pathogenesis of HL will eventually lead to the development of novel biologically based therapeutic strategies in the near future.
引用
收藏
页码:6379 / 6386
页数:8
相关论文
共 79 条
[1]   Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease, represent clonal populations of germinal center-derived tumor B cells [J].
Braeuninger, A ;
Kuppers, R ;
Strickler, JG ;
Wacker, HH ;
Rajewsky, K ;
Hansmann, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9337-9342
[2]   Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma [J].
Bräuninger, A ;
Hansmann, ML ;
Strickler, JG ;
Dummer, R ;
Burg, G ;
Rajewsky, K ;
Küppers, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) :1239-1247
[3]   Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα [J].
Cabannes, E ;
Khan, G ;
Aillet, F ;
Jarrett, RF ;
Hay, RT .
ONCOGENE, 1999, 18 (20) :3063-3070
[4]   Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals [J].
Caldwell, RG ;
Wilson, JB ;
Anderson, SJ ;
Longnecker, R .
IMMUNITY, 1998, 9 (03) :405-411
[5]  
Carbone A, 1998, BLOOD, V92, P2220
[6]  
CARBONE A, 1995, AM J PATHOL, V147, P912
[7]   B cell receptor signal strength determines B cell fate [J].
Casola, S ;
Otipoby, KL ;
Alimzhanov, M ;
Humme, S ;
Uyttersprot, N ;
Kutok, JL ;
Carroll, MC ;
Rajewsky, K .
NATURE IMMUNOLOGY, 2004, 5 (03) :317-327
[8]  
Chan WC, 1999, SEMIN HEMATOL, V36, P242
[9]  
Chhanabhai M, 1997, BLOOD, V90, P2451
[10]   Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death [J].
Dutton, A ;
O'Neil, JD ;
Milner, AE ;
Reynolds, GM ;
Starczynski, J ;
Crocker, J ;
Young, LS ;
Murray, PG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (17) :6611-6616